Original Article

You have full text access to this OnlineOpen article

Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus†

  1. Giri R. Gupta MD1,
  2. Alan W. Yasko MD2,
  3. Valerae O. Lewis MD1,
  4. Christopher P. Cannon MD1,
  5. A. Kevin Raymond MD3,
  6. Shreyaskumar Patel MD4,
  7. Patrick P. Lin MD1,‡,*

Article first published online: 10 JUN 2009

DOI: 10.1002/cncr.24443

Issue

Cancer

Cancer

Volume 115, Issue 16, pages 3767–3773, 15 August 2009

Additional Information

How to Cite

Gupta, G. R., Yasko, A. W., Lewis, V. O., Cannon, C. P., Raymond, A. K., Patel, S. and Lin, P. P. (2009), Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer, 115: 3767–3773. doi: 10.1002/cncr.24443

Author Information

  1. 1

    Department of Orthopedic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois

  3. 3

    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  4. 4

    Department of Sarcoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. ‡

    Fax: (713) 792-8448

*Department of Orthopedic Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 408, PO Box 301402, Houston, TX 77230

  1. †

    Presented at the 12th Annual Meeting of the Connective Tissue Oncology Society, Venice, Italy, November 2-4, 2006.

Publication History

  1. Issue published online: 3 AUG 2009
  2. Article first published online: 10 JUN 2009
  3. Manuscript Accepted: 27 JAN 2009
  4. Manuscript Revised: 14 JAN 2009
  5. Manuscript Received: 8 SEP 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (275K)

References

  • 1
    Malawer MM. Tumors of the shoulder girdle. Technique of resection and description of a surgical classification. Orthop Clin North Am. 1991; 22: 7-35.
  • 2
    Wittig JC, Bickels J, Kellar-Graney KL, Kim FH, Malawer MM. Osteosarcoma of the proximal humerus: long-term results with limb-sparing surgery. Clin Orthop Relat Res. 2002; (397): 156-176.
  • 3
    Gebhardt MC, Roth YF, Mankin HJ. Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor. J Bone Joint Surg Am. 1990; 72: 334-345.
  • 4
    Getty PJ, Peabody TD. Complications and functional outcomes of reconstruction with an osteoarticular allograft after intra-articular resection of the proximal aspect of the humerus. J Bone Joint Surg Am. 1999; 81: 1138-1146.
  • 5
    Jensen KL, Johnston JO. Proximal humeral reconstruction after excision of a primary sarcoma. Clin Orthop Relat Res. 1995; (311): 164-175.
  • 6
    O'Connor MI, Sim FH, Chao EY. Limb salvage for neoplasms of the shoulder girdle. Intermediate reconstructive and functional results. J Bone Joint Surg Am. 1996; 78: 1872-1888.
  • 7
    Voggenreiter G, Assenmacher S, Schmit-Neuerburg KP. Tikhoff-Linberg procedure for bone and soft tissue tumors of the shoulder girdle. Arch Surg. 1999; 134: 252-257.
  • 8
    De Wilde LF, Plasschaert FS, Audenaert EA, Verdonk RC. Functional recovery after a reverse prosthesis for reconstruction of the proximal humerus in tumor surgery. Clin Orthop Relat Res. 2005; (430): 156-162.
  • 9
    Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980; (153): 106-120.
  • 10
    Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977; 101: 14-18.
  • 11
    Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005; 23: 2004-2011; comment, 2005;23:6437-6438.
  • 12
    Jaffe N. Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)–advantages, disadvantages, and controversial issues. Cancer Treat Res. 1993; 62: 75-84.
  • 13
    Eckardt JJ, Eilber FR, Rosen G, et al. Endoprosthetic replacement for stage IIB osteosarcoma. Clin Orthop Relat Res. 1991; (270): 202-213.
  • 14
    Picci P, Sangiorgi L, Rougraff BT, Neff JR, Casadei R, Campanacci M. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994; 12: 2699-2705; comment, 1996;12:2699-2705.
  • 15
    Grimer RJ, Sommerville S, Warnock D, et al. Management and outcome after local recurrence of osteosarcoma. Eur J Cancer. 2005; 41: 578-583.
  • 16
    Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am. 1994; 76: 649-656.
  • 17
    Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC. Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am. 2002; 84-A: 49-57; erratum, 2002;84-A:622; comment, 2003;85-A:1848.
  • 18
    Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies. Cancer. 1983; 51: 402-407.
    Direct Link:
  • 19
    Kumar D, Grimer RJ, Abudu A, Carter SR, Tillman RM. Endoprosthetic replacement of the proximal humerus. Long-term results. J Bone Joint Surg Br. 2003; 85: 717-722.
View Full Article (HTML) Get PDF (275K)